Our Approach

Qualigen is a biotechnology company committed to developing new therapeutics for adult and pediatric patients with rare cancers, as well as expansion of its flagship

FastPack® diagnostic platform. The FastPack® line of FDA-cleared and CE-Marked products has been used successfully in diagnostics since 2002.

More About Us

Our Therapeutics Pipeline

Our therapeutics pipeline includes cancer drug compounds such as QN-302, RAS and QN-247.

Select a Drug Candidate to Learn More